XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Common Class A
Additional paid in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021     81,211,781    
Beginning balance at Dec. 31, 2021 $ 131,888   $ 1 $ 340,570 $ (208,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)     170,751    
Issuance of common stock upon exercise of stock options 48     48  
Issuance of common stock upon vesting of RSUs (in shares)     113,710    
Share repurchase related to Section 16 Officer tax coverage exchange (in shares)     (18,673)    
Share repurchase related to Section 16 Officer tax coverage exchange (59)     (59)  
Stock-based compensation - stock options, RSAs, RSUs 2,212     2,212  
Share repurchase valuation adjustment (6,000)     (6,000)  
Shares issued upon exercise of warrant (in shares)     278,146    
Net loss (26,834)       (26,834)
Ending balance (in shares) at Mar. 31, 2022     81,755,715    
Ending balance at Mar. 31, 2022 101,255   $ 1 336,771 (235,517)
Beginning balance (in shares) at Dec. 31, 2021     81,211,781    
Beginning balance at Dec. 31, 2021 131,888   $ 1 340,570 (208,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (49,706)        
Ending balance (in shares) at Jun. 30, 2022     83,264,832    
Ending balance at Jun. 30, 2022 82,205   $ 1 340,593 (258,389)
Beginning balance (in shares) at Mar. 31, 2022     81,755,715    
Beginning balance at Mar. 31, 2022 101,255   $ 1 336,771 (235,517)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)     1,294,668    
Issuance of common stock upon exercise of stock options 345     345  
Issuance of common stock upon vesting of RSUs (in shares)     149,953    
Issuance of common stock upon purchase of ESPP (in shares)   77,162      
Issuance of common stock upon purchase of ESPP 190     190  
Share repurchase related to Section 16 Officer tax coverage exchange (in shares)     (12,666)    
Share repurchase related to Section 16 Officer tax coverage exchange (38)     (38)  
Stock-based compensation - stock options, RSAs, RSUs 3,105     3,105  
Share repurchase valuation adjustment 220     220  
Net loss (22,872)       (22,872)
Ending balance (in shares) at Jun. 30, 2022     83,264,832    
Ending balance at Jun. 30, 2022 $ 82,205   $ 1 340,593 (258,389)
Beginning balance (in shares) at Dec. 31, 2022 84,441,153   84,441,153    
Beginning balance at Dec. 31, 2022 $ 38,607   $ 1 342,733 (304,127)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)     370,287    
Issuance of common stock upon exercise of stock options 92     92  
Issuance of common stock upon vesting of RSUs (in shares)     766,791    
Share repurchase related to Section 16 Officer tax coverage exchange (in shares)     (124,899)    
Share repurchase related to Section 16 Officer tax coverage exchange (60)     (60)  
Stock-based compensation - stock options, RSAs, RSUs 1,720     1,720  
Issuance of common stock and related warrants in registered offering, net of issuance costs (in shares)     9,396,000    
Issuance of common stock and related warrants in registered offering, net of issuance costs 9,300     9,300  
Issuance of common stock to non-employees (in shares)     135,000    
Issuance of common stock to non-employees 112     112  
Net loss (20,825)       (20,825)
Ending balance (in shares) at Mar. 31, 2023     94,984,332    
Ending balance at Mar. 31, 2023 $ 28,946   $ 1 353,897 (324,952)
Beginning balance (in shares) at Dec. 31, 2022 84,441,153   84,441,153    
Beginning balance at Dec. 31, 2022 $ 38,607   $ 1 342,733 (304,127)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 502,704        
Net loss $ (39,660)        
Ending balance (in shares) at Jun. 30, 2023 97,865,351   97,865,351    
Ending balance at Jun. 30, 2023 $ 12,757   $ 1 356,543 (343,787)
Beginning balance (in shares) at Mar. 31, 2023     94,984,332    
Beginning balance at Mar. 31, 2023 28,946   $ 1 353,897 (324,952)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)     132,417    
Issuance of common stock upon exercise of stock options 38     38  
Issuance of common stock upon vesting of RSUs (in shares)     472,014    
Issuance of common stock upon purchase of ESPP (in shares)   106,545      
Issuance of common stock upon purchase of ESPP $ 31     31  
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares) 2,170,043   2,170,043    
Stock-based compensation - stock options, RSAs, RSUs $ 2,577     2,577  
Net loss $ (18,835)       (18,835)
Ending balance (in shares) at Jun. 30, 2023 97,865,351   97,865,351    
Ending balance at Jun. 30, 2023 $ 12,757   $ 1 $ 356,543 $ (343,787)